Home > Boards > US Listed > Medical - Healthcare >

Predictive Oncology Inc. (POAI)

Add POAI Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 3/31/2020 8:38:47 AM - Followers: 94 - Board type: Free - Posts Today: 0


Jan 25, 2018

Skyline Medical Announces Corporate Name Change to Precision Therapeutics





Skyline Medical Inc. Enters into Strategic Collaboration with Helomics to Develop Next Generation of Personalized Cancer Diagnostics

Skyline Medical Inc. (NASDAQ: SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, and Helomics Corporation (Pittsburgh, PA)  have announced a strategic collaboration to use the Helomics D-CHIP™ platform to develop new approaches for personalized cancer diagnosis and care.

Skyline Medical and Helomics expand into Next Generation Sequencing for Personalized Medicine

"The MiSeqDx NGS platform will allow gene sequencing of tumor specimens from cancer patients which will provide rich genomic data for the D-CHIP™ AI-based bioinformatics platform being built out as part of the Skyline-Helomics joint venture. The D-CHIP platform then identifies the correlations between the patient demographic data, the tumor gene sequence (obtained by NGS), and the drug responses of the individual patient’s tumor. Pharma partners who subscribe to the D-CHIP service can mine the knowledgebase of tumor mutations and drug response to design the next generation of cancer treatments.

“Licensing the NGS platform is expected to drive commercial traction for both the D-CHIP platform and the additional CRO services offered by the Skyline-Helomics joint venture. We fully expect the NGS platform to drive revenue from new partnerships early in 2018,” stated Dr. Carl Schwartz, CEO of Skyline Medical." 


Helomics® Corporation Announces the appointment of Dr. Marc Malandro to its Advisory Board, providing strategic insights for the Skyline Medical – Helomics Joint Venture.



Chan-Zuckerberg: Social Media Monarchy Breeds Philanthropy

A recent BioBreakfast event welcomed Marc Malandro, VP of operations for science at the Chan Zuckerberg Initiative (CZI), back to the city of Pittsburgh. Malandro previously served as Vice Chancellor for Technology Management and Commercialization, as well as Founding Director of the Innovation Institute, at the University of Pittsburgh. Under his leadership, the university filed over 1,100 new U.S. patent applications, was granted 609 U.S. issued patents, entered into over 1,203 license agreements, and formed 86 companies based on university research. Malandro’s productive tenure at Pitt began in 2004 and lasted until his departure for CZI earlier this year.

In his new role, Malandro is part of the CZI team supporting novel advances in the scientific research behind modern medicine. To accelerate this progress, CZI will bring scientists and engineers together in new ways, create computational and experimental tools to empower the scientific community, and build a movement to support basic scientific research. But, where did CZI come from?


CZI is inseparably linked to the modest beginnings of social media monster Facebook. In January of 2004, then Harvard student Mark Zuckerberg began writing code for a new web site in his dorm room. On Feb. 4, 2004, Zuckerberg launched "Thefacebook," originally located at thefacebook.com. This became the Facebook so many people know and love; it currently is valued at about $500 billion, and Zuckerberg owns about 20 percent of the shares outstanding.


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
POAI News: Initial Statement of Beneficial Ownership (3) 02/21/2020 08:31:37 AM
POAI News: Current Report Filing (8-k) 02/21/2020 08:31:06 AM
POAI News: Predictive Oncology Inc. Appoints Dan Handley, M.S., Ph.D. to Board of Directors 02/21/2020 08:30:10 AM
POAI News: Unknown (sec Staff) 02/19/2020 04:54:16 PM
POAI News: Initial Statement of Beneficial Ownership (3) 02/12/2020 03:23:27 PM
#4095   POAI Subsidiary Helomics Continues Progress Towards Goal of Paullee 03/31/20 08:38:46 AM
#4094   * * $POAI Video Chart 03-12-2020 * * ClayTrader 03/12/20 06:17:28 PM
#4093   So many monsters today. UP Trend 03/12/20 10:17:46 AM
#4092   Low floater with CV news. UP Trend 03/12/20 08:33:54 AM
#4091   Karl and Bob are reviewing the Dr Nassar Full Contact Yoga 03/04/20 11:08:25 PM
#4090   * * $POAI Video Chart 02-05-2020 * * ClayTrader 02/05/20 06:04:54 PM
#4089   Hod test power hour... Liquid1974 02/05/20 01:18:04 PM
#4088   $11.50 52 wk/hi... HMMMM Liquid1974 02/05/20 12:56:34 PM
#4087   HOD close today... Liquid1974 02/05/20 12:54:54 PM
#4086   Nice day. I knew all it needed was Watkins 02/05/20 11:26:12 AM
#4085   4,12 I mean lol europtiger 02/05/20 10:14:14 AM
#4084   In average 1,12 europtiger 02/05/20 10:09:04 AM
#4083   $ $ $ $ - looking good POAI speedstar 02/05/20 09:56:20 AM
#4082   $POAI: WOW......... on FIREREeeeeeeeeeee makinezmoney 02/05/20 09:42:11 AM
#4081   Predictive Oncology Launches Innovative Specialty Media for Growing Paullee 02/05/20 09:12:11 AM
#4080   Where will the money come from? These clowns Bikesouth 01/26/20 09:32:33 PM
#4079   POAI: applies AI to data bases. This swampboots 01/25/20 08:30:53 PM
#4078   Predictive Oncology Inc. Signs Letter of Intent to Paullee 01/24/20 05:37:52 PM
#4077   Q1 2020 remains the goal for Helomics to 77Port 01/11/20 03:42:54 AM
#4076   Predictive Oncology Provides Updates on Commercialization of Its Paullee 12/09/19 09:08:40 AM
#4075   What is going on speedstar 12/03/19 02:01:12 PM
#4074   does this have SGLB inside ? Paullee 11/20/19 09:12:14 AM
#4073   Anyone have an opinion on what this could speedstar 11/12/19 01:16:52 PM
#4072   I'm liking this! Pinkballer7 11/05/19 03:00:01 PM
#4071   New Hope in the Battle Against Ovarian Cancer NetworkNewsWire 11/05/19 11:23:11 AM
#4070   Revenue going out to pay for branding articles 77Port 10/30/19 04:18:05 AM
#4069   Delivering Precision Medicine’s True Potential: Big Data, Artificial NetworkNewsWire 10/29/19 09:05:10 AM
#4068   Karl and Bob, the Epstein and Sandusky of Full Contact Yoga 10/06/19 09:25:01 PM
#4067   No warrants - good sign Cphelan23 10/04/19 07:53:25 AM
#4066   Some NEWS today ?????? speedstar 10/02/19 03:27:41 PM
#4065   I will be voting NO!!! Jamesthe1 09/20/19 06:51:48 PM
#4064   http://investors.skylinemedical.com/node/11726/html http://invest 77Port 09/19/19 02:26:46 PM
#4063   For what?? speedstar 09/18/19 04:24:44 PM
#4062   Yep. 77Port 09/17/19 07:44:58 PM
#4061   Buckle up ! Cphelan23 09/17/19 07:28:13 PM
#4060   I BELIEVE IT'S TIME TO COME TO THE Bona Vista 09/03/19 02:10:07 PM
#4059   The Skyline scam turned into the R-AIPT scam Full Contact Yoga 07/12/19 12:15:02 AM
#4058   I guess that's what happened today. 77Port 07/11/19 06:27:59 PM
#4057   No matter what you call it Carl and Full Contact Yoga 06/13/19 06:38:09 PM
#4056   Just hit 40 cents. willlbone 05/22/19 11:30:38 AM
#4055   Today's release is about the relatively rare condition 77Port 04/18/19 03:05:51 PM
#4054   I don't disagree that they are expert 3-Card 77Port 04/16/19 03:24:04 PM
#4053   I see nothing has changed over at RAIPT, Full Contact Yoga 04/16/19 03:10:56 PM
#4052   Recently, Skyline Medical even received word that India efhutton1 04/11/19 07:03:40 PM
#4051   Uptick Newswire Hosts Precision Therapeutics Inc. on The Paullee 04/11/19 11:13:27 AM
#4050   Precision Therapeutics’ Subsidiary, Helomics® Corporation, and SpeciCare, Inc. Paullee 04/11/19 09:02:53 AM
#4048   Risk vs. Reward is high. Not for the Krspecialized 03/30/19 11:04:37 AM
#4047   Yes, Viewmont, this seems to the big bet. 77Port 03/29/19 04:19:38 PM
#4046   Yoga, I'm not yet at your level of 77Port 03/29/19 04:15:39 PM
#4045   Good to see Karl and Bob have never Full Contact Yoga 03/28/19 08:51:45 PM